THULIN INGE G has filed 4 insider transactions across 1 company since May 2023.
Most recent transaction: a grant/award of 2863 shares of Merck & Co., Inc. ($MRK) on May 30, 2025.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 30, 2025 | Merck & Co., Inc. | $MRK | THULIN INGE G | Director | A | Phantom Stock | 2863 | $76.84 | 24,764.2900 | 2,541,000,000 | 13.07% | 0.00% |
| Feb. 6, 2025 | Merck & Co., Inc. | $MRK | THULIN INGE G | Director | P | Common Stock | 2833 | $88.25 | 2,932.8610 | 2,541,000,000 | 2832.86% | 0.00% |
| May 31, 2024 | Merck & Co., Inc. | $MRK | THULIN INGE G | Director | A | Phantom Stock | 1752 | $125.54 | 21,228.9219 | 2,547,000,000 | 9.00% | 0.00% |
| May 26, 2023 | Merck & Co., Inc. | $MRK | THULIN INGE G | Director | A | Phantom Stock | 1981 | $111.07 | 18,973.6684 | 2,542,000,000 | 11.66% | 0.00% |